{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:53:49Z","timestamp":1782467629950,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 137073"],"award-info":[{"award-number":["MOP 137073"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.drugpo.2017.03.014","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T02:47:06Z","timestamp":1493174826000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000\u20132015"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9947-7428","authenticated-orcid":false,"given":"T. Cameron","family":"Wild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernie","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2469-3468","authenticated-orcid":false,"given":"Lynne","family":"Belle-Isle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Cavalieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Strike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Tupper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hathaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Dell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"MacPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamagaju","family":"Karekezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Hyshka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2017.03.014_bib0005","series-title":"Hard time: HIV and hepatitis C prevention programming for prisoners in Canada","author":"Betteridge","year":"2007"},{"issue":"2","key":"10.1016\/j.drugpo.2017.03.014_bib0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.15453\/0191-5096.3669","article-title":"Clean needles and bad blood: Needle exchange as morality policy","volume":"39","author":"Bowen","year":"2012","journal-title":"Journal of Sociology & Social Welfare"},{"issue":"4","key":"10.1016\/j.drugpo.2017.03.014_bib0015","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s11524-012-9673-y","article-title":"Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: A longitudinal multilevel study","volume":"89","author":"Cooper","year":"2012","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0020","series-title":"Hard time: HIV and hepatitis C prevention programming for prisoners in Canada","author":"Dias","year":"2007"},{"issue":"September (3)","key":"10.1016\/j.drugpo.2017.03.014_bib0025","first-page":"e167","article-title":"The use of knowledge translation and legal proceedings to support evidence-based drug policy in Canada: Opportunities and ongoing challenges","volume":"4","author":"DeBeck","year":"2010","journal-title":"Open Medince"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0030","series-title":"Canadian case studies in health policy and management","author":"Deber","year":"2014"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0035","series-title":"Evidence-based health economics","author":"Donaldson","year":"2002"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0040","first-page":"4","article-title":"Community based naloxone: A Canadian pilot program","volume":"3","author":"Dong","year":"2012","journal-title":"Canadian Journal of Addiction Medicine"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF03404331","article-title":"Revisiting our social justice roots in population health interventionresearch","volume":"100","author":"Edwards","year":"2009","journal-title":"Canadian Journal of Public Health"},{"issue":"3","key":"10.1016\/j.drugpo.2017.03.014_bib0050","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/13501763.2013.761506","article-title":"From morality policy to normal policy: Framing of drug consumption and gambling in Germany and the Netherlands and their regulatory consequences","volume":"20","author":"Euchner","year":"2013","journal-title":"Journal of European Public Policy"},{"issue":"6","key":"10.1016\/j.drugpo.2017.03.014_bib0055","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s11524-012-9698-2","article-title":"Public health understandings of policy and power: Lessons from INSITE","volume":"89","author":"Fafard","year":"2012","journal-title":"Journal of Urban Health"},{"issue":"2","key":"10.1016\/j.drugpo.2017.03.014_bib0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1017\/S0003055404001182","article-title":"What is a case study and what is it good for?","volume":"98","author":"Gerring","year":"2004","journal-title":"American Political Science Review"},{"issue":"5","key":"10.1016\/j.drugpo.2017.03.014_bib0065","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3109\/10826089809062211","article-title":"Syringe exchange in Canada: Good but not good enough to stem the HIV tide","volume":"33","author":"Hankins","year":"1998","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0955-3959(01)00085-8","article-title":"Shortcomings of harm reduction: Toward a morally invested drug reform strategy","volume":"12","author":"Hathaway","year":"2001","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugpo.2007.11.006","article-title":"Harm reduction headway and continuing resistance: Insights from safe injection in the city of Vancouver","volume":"19","author":"Hathaway","year":"2008","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2017.03.014_bib0080","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/13501763.2013.761497","article-title":"Public policy meets morality: Conceptual and theoretical challenges in the analysis of morality policy change","volume":"20","author":"Heichel","year":"2013","journal-title":"Journal of European Public Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2017.03.014_bib0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2105\/AJPH.2008.136937","article-title":"Expanded access to naloxone: Options for critical response to the epidemic of opioid overdose mortality","volume":"99","author":"Kim","year":"2009","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0090","series-title":"Harm reduction: Evidence, impacts, challenges EMCDDA monographs","article-title":"Harm reduction among injection drug users-evidence of effectiveness","author":"Kimber","year":"2010"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0095","series-title":"Improving governance: A new logic forempirical research","author":"Lynn","year":"2001"},{"issue":"11","key":"10.1016\/j.drugpo.2017.03.014_bib0100","article-title":"Impact: A case study examining the closure of a large urban fixed site needle exchange in Canada","volume":"7","author":"MacNeil","year":"2010","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0105","series-title":"Health systems in transition: Canada","author":"Marchildon","year":"2006"},{"issue":"7","key":"10.1016\/j.drugpo.2017.03.014_bib0110","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"6","key":"10.1016\/j.drugpo.2017.03.014_bib0115","doi-asserted-by":"crossref","DOI":"10.1007\/s11524-008-9312-9","article-title":"The North American Opiate Medication Initiative (NAOMI): Profile of participants in North American\u2019s first trial of heroin-assisted treatment","volume":"85","author":"Oviedo-Joekes","year":"2008","journal-title":"Journal of Urban Health: Bulletin of the New York Academy of Medicine"},{"issue":"2","key":"10.1016\/j.drugpo.2017.03.014_bib0120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.healthplace.2011.08.016","article-title":"Access to harm reduction services in Atlantic Canada: Implications for non-urban residents who inject drugs","volume":"18","author":"Parker","year":"2012","journal-title":"Health and Place"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0125","series-title":"Prevention vs. treatment: What\u2019s the right balance?","first-page":"96","article-title":"Prevention and the science and politics of evidence","author":"Pettiti","year":"2012"},{"issue":"1","key":"10.1016\/j.drugpo.2017.03.014_bib0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/phe\/phr001","article-title":"The expressive function of public health policy: The case of pandemic planning","volume":"4","author":"Pierce","year":"2011","journal-title":"Public Health Ethics"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0135","series-title":"EMCDDA monographs","article-title":"Harm reduction: Evidence, impacts, challenges","author":"Rhodes","year":"2010"},{"issue":"3","key":"10.1016\/j.drugpo.2017.03.014_bib0140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/dar.12374","article-title":"Twenty years of (non)reform in Victorian alcohol and otherdrug treatment policy","volume":"35","author":"Ritter","year":"2016","journal-title":"Drug and Alcohol Review"},{"issue":"6","key":"10.1016\/j.drugpo.2017.03.014_bib0145","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/09595230600944529","article-title":"A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs","volume":"25","author":"Ritter","year":"2006","journal-title":"Drug & Alcohol Review"},{"issue":"7023","key":"10.1016\/j.drugpo.2017.03.014_bib0150","first-page":"871","article-title":"Evidence based medicine: What it is and what it isn\u2019t","volume":"312","author":"Sackett","year":"1995","journal-title":"British Medical Journal"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0155","series-title":"Multiple case study analysis","author":"Stake","year":"2006"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1377\/hlthaff.24.1.80","article-title":"Evidence based? Caveat emptor!","volume":"24","author":"Steinberg","year":"2005","journal-title":"Health Affairs"},{"issue":"3","key":"10.1016\/j.drugpo.2017.03.014_bib0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09581590400004386","article-title":"Finding a place for needle exchange programs","volume":"14","author":"Strike","year":"2004","journal-title":"Critical Public Health"},{"issue":"9810","key":"10.1016\/j.drugpo.2017.03.014_bib0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(11)61674-7","article-title":"Drug policy and the public good: Evidence for effective interventions","volume":"379","author":"Strang","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0175","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2307\/3312647","article-title":"On the expressive function of law","volume":"144","author":"Sunstein","year":"1996","journal-title":"University of Pennsylvania Law Review"},{"issue":"1","key":"10.1016\/j.drugpo.2017.03.014_bib0180","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.drugpo.2008.02.002","article-title":"Drugscapes and the role of place and space in injection drug use-related HIV risk environments","volume":"20","author":"Tempalski","year":"2009","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2017.03.014_bib0185","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2105\/AJPH.2005.065961","article-title":"Social and political factors predicting the presence of syringe exchange programs in 96 US Metropolitan areas","volume":"97","author":"Tempalski","year":"2007","journal-title":"American Journal of Public Health"},{"issue":"6","key":"10.1016\/j.drugpo.2017.03.014_bib0190","first-page":"100","article-title":"Community-based opioid overdose prevention programs providing naloxone\u2014United States, 2010","volume":"61","author":"Wheeler","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-7517-3-36","article-title":"HIV seroprevalence among participants at a supervised injection facility in Vancouver, Canada: Implications for prevention, care and treatment","volume":"3","author":"Tyndall","year":"2006","journal-title":"Harm Reduction Journal"},{"issue":"7","key":"10.1016\/j.drugpo.2017.03.014_bib0200","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1503\/cmaj.1040774","article-title":"Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users","volume":"171","author":"Wood","year":"2004","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.drugpo.2017.03.014_bib0205","series-title":"Summary of emerging findings from the 2007 National Inmate Infectious Diseases and Risk-behaviours Survey","author":"Zakaria","year":"2010"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917300889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917300889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T08:29:32Z","timestamp":1692779372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917300889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":41,"alternative-id":["S0955395917300889"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.03.014","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000\u20132015","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}